Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of Neuroendocrinology"
DOI: 10.1111/jne.13196
Abstract: The COVID‐19 outbreak has added complexity in the management of patients with neuroendocrine tumors (NETs). Little information is currently available regarding the real impact of the pandemic in current practice. The present study aimed to…
read more here.
Keywords:
net patients;
neuroendocrine tumors;
management;
tumors nets ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.4088
Abstract: 4088Background: In ELECT, LAN significantly reduced the need for short-acting OCT rescue therapy for symptomatic control of CS in NET patients (pts) vs placebo (PBO) (primary result). Here we prese...
read more here.
Keywords:
net patients;
symptomatic control;
lanreotide depot;
depot lan ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Cancers"
DOI: 10.3390/cancers13112634
Abstract: Simple Summary Metabolic flexibility is one of the key hallmarks of cancer and metabolites are the final products of this adaptation, reflecting the aberrant changes of tumors. However, the metabolic plasticity of each cancer type…
read more here.
Keywords:
net patients;
metabolomic profile;
profile net;
neuroendocrine tumors ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Diagnostics"
DOI: 10.3390/diagnostics13040606
Abstract: Background: this study aims to explore the prognostic and predictive role of volumetric parameters on [68Ga]Ga-DOTATOC PET/CT in neuroendocrine tumors (NET) patients treated with peptide receptor radionuclide therapy (PRRT). Methods: We retrospectively evaluated 39 NET…
read more here.
Keywords:
68ga dotatoc;
dotatoc pet;
net patients;
patients treated ... See more keywords